These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12739834)

  • 1. Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio.
    Kalousová M; Sulková S; Zima T; Deppisch R; Beck W; Bednárová sV; Fortová M; Tesar V
    Ren Fail; 2003 Mar; 25(2):277-86. PubMed ID: 12739834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients.
    Kalousová M; Zima T; Tesar V; Lachmanová J
    Blood Purif; 2002; 20(6):531-6. PubMed ID: 12566668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes.
    Dolhofer-Bliesener R; Lechner B; Gerbitz KD
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):355-61. PubMed ID: 8704053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.
    Uribarri J; Peppa M; Cai W; Goldberg T; Lu M; Baliga S; Vassalotti JA; Vlassara H
    Am J Kidney Dis; 2003 Sep; 42(3):532-8. PubMed ID: 12955681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leptin levels in diabetic patients on hemodialysis: the relationship to parameters of diabetes metabolic control.
    Haluzik M; Sulková S; Svobodová J; Bedárová V; Bodláková B; Marková M; Turková G; Jiskra J; Haas T
    Endocr Res; 2000 May; 26(2):303-17. PubMed ID: 10921455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.
    Kostolanská J; Jakus V; Barák L
    J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
    Bucala R; Makita Z; Vega G; Grundy S; Koschinsky T; Cerami A; Vlassara H
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9441-5. PubMed ID: 7937786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD.
    Papanastasiou P; Grass L; Rodela H; Patrikarea A; Oreopoulos D; Diamandis EP
    Kidney Int; 1994 Jul; 46(1):216-22. PubMed ID: 7933840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
    Farhan SS; Hussain SA
    Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis.
    Freedman BI; Shenoy RN; Planer JA; Clay KD; Shihabi ZK; Burkart JM; Cardona CY; Andries L; Peacock TP; Sabio H; Byers JR; Russell GB; Bleyer AJ
    Perit Dial Int; 2010; 30(1):72-9. PubMed ID: 20056983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality.
    Gerdemann A; Wagner Z; Solf A; Bahner U; Heidland A; Vienken J; Schinzel R
    Nephrol Dial Transplant; 2002 Jun; 17(6):1045-9. PubMed ID: 12032195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse association of fat mass, but not lean mass, with glycated albumin in hemodialysis patients with or without diabetes mellitus.
    Miyawaki J; Okuno S; Mori K; Nishio E; Norimine K; Kurajoh M; Yamakawa T; Shoji S; Inaba M
    Ren Fail; 2019 Nov; 41(1):808-813. PubMed ID: 31498022
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy.
    Loho T; Venna V; Setiabudy RD; Sukartini N; Immanuel S; Kumalawati J; Victor AA; Waspadji S
    Acta Med Indones; 2018 Apr; 50(2):132-137. PubMed ID: 29950532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
    Lapolla A; Reitano R; Seraglia R; Sartore G; Ragazzi E; Traldi P
    Mol Nutr Food Res; 2005 Jul; 49(7):685-90. PubMed ID: 15926142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of advanced glycation end products in poorly metabolically controlled children with diabetes mellitus: relation to HbA1c.
    Jakus V; Bauerová K; Michalková D; Cársky J
    Diabetes Nutr Metab; 2001 Aug; 14(4):207-11. PubMed ID: 11716290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between advanced glycation end-products and the expression of fatty inflammatory factors in type II diabetic cardiomyopathy.
    Guo Z; Huang D; Tang X; Han J; Li J
    Bosn J Basic Med Sci; 2015 Oct; 15(4):15-9. PubMed ID: 26614846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum advanced glycosylation end-products in patients on hemodialysis and CAPD.
    Ateshkadi A; Johnson CA; Founds HW; Zimmerman SW
    Perit Dial Int; 1995; 15(2):129-33. PubMed ID: 7612732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.